Fast-disintegrating sublingual epinephrine tablets: Effect of tablet dimensions on tablet characteristics

被引:19
作者
Rawas-Qalaji, Mutasem M.
Simons, F. Estelle R.
Simons, Keith J.
机构
[1] Univ Manitoba, Fac Pharm, Winnipeg, MB R3T 2N2, Canada
[2] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Allergy & Clin Immunol Sect, Winnipeg, MB, Canada
[3] Univ Manitoba, Fac Med, Winnipeg, MB, Canada
关键词
sublingual; fast-disintegrating tablets; epinephrine; anaphylaxis;
D O I
10.1080/03639040600897150
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to evaluate the effect of changing dimensions on the hardness ( H), disintegration time ( DT), and wetting time (WT) of fast-disintegrating epinephrine tablets for sublingual administration as potential first aid treatment for anaphylaxis. Tablet formulations I and II, containing 0% and 10% epinephrine bitartrate, respectively, and weighing 150 mg were prepared by direct compression. Formulations were compressed at a range of forces using an 8/32 '' die with concave punches (CP); a 10/32 '' and an 11/32 '' die with CP and flat punches ( FP). Tablet weight variation, content uniformity, thickness, H, DT, and WT were measured. The 8/32 '', 10/32 '', and 11/32 '' dies resulted in tablet thickness of ranges 0.25 - 0.19 '', 0.17 - 0.1 '', and 0.16 - 0.08 '', respectively. The DT and WT using the 8/32 '' die were <= 10 and <= 30 sec, respectively, at H <= 5.4 +/- 0.2 kg for formulation I, and H <= 5.4 +/- 0.3 kg for formulation II. The DT and WT were = 10 and = 30 sec, respectively, using 10/32 '' die/CP, 10/32 '' die/FP, 11/32 '' die/CP, and 11/32 '' die/FP at H <= 6.2 +/- 0.6 kg, <= 6.8 +/- 0.4 kg, <= 4.9 +/- 0.1 kg, and <= 7.2 +/- 0.3 kg, respectively, for formulation I. For formulation II, the DT and WT were = 10 sec and = 30 sec, respectively, when H < 4 kg. No difference in DT and WT was observed between concave and flat tablets. The 11/32 '' and 10/32 '' dies resulted in more ideal tablet dimensions for sublingual administration, but H must be maintained < 4 kg to ensure rapid DT and WT.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 26 条
[1]  
ALLEN LV, 2003, UPC, V7, P449
[2]  
Amidon G. L., 1986, CHEM STABILITY PHARM
[3]  
[Anonymous], [No title captured]
[4]  
Bi YX, 1996, CHEM PHARM BULL, V44, P2121
[5]   Evaluation of rapidly disintegrating tablets prepared by a direct compression method [J].
Bi, YX ;
Sunada, H ;
Yonezawa, Y ;
Danjo, K .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (05) :571-581
[6]   In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance [J].
Bredenberg, S ;
Duberg, M ;
Lennernäs, B ;
Lennernäs, H ;
Pettersson, A ;
Westerberg, M ;
Nyström, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (03) :327-334
[7]   COMPARATIVE PHARMACOKINETICS OF ORAL VERSUS SUBLINGUAL CLONIDINE [J].
CUNNINGHAM, FE ;
BAUGHMAN, VL ;
PETERS, J ;
LAURITO, CE .
JOURNAL OF CLINICAL ANESTHESIA, 1994, 6 (05) :430-433
[8]   Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies [J].
Fu, YR ;
Yang, SC ;
Jeong, SH ;
Kimura, S ;
Park, K .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2004, 21 (06) :433-475
[9]  
Gilman, 1996, GOODMAN GILMANS PHAR, P105
[10]   Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low-substituted hydroxypropylcellulose or spherical sugar granules by direct compression method [J].
Ishikawa, T ;
Mukai, B ;
Shiraishi, S ;
Utoguchi, N ;
Fujii, M ;
Matsumoto, M ;
Watanabe, Y .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (02) :134-139